1.A novel anticancer natural product SP09 selectively targets KRAS-mutant NSCLC through LKB1/AMPK/mTOR modulation: implications for novel therapeutic development
Yue, P, Hon, C, Zhao
More...
Yue, P, Hon, C, Zhao, XP, Ali, F, Sun, JY, Kou, JY
Less
Anti-cancer Drugs[0959-4973],
Published 2025,
Volume 37,
Issue 2,
Pages 137-145
收錄情况:
WOS
SCOPUS
WOS核心合集引用: 0
2024影響因子:
2.2